| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |